Leidos Holdings, Inc.
Time frame: 1 April 2023 - 31 March 2024Article ‘Count’ and ‘Share’ for Leidos Holdings, Inc. based on listed parameters only.
The articles listed below published by authors from Leidos Holdings, Inc., organized by journal and article, represent the research output in Count and Share according to the parameters selected above.
Journal | Count | Share |
---|---|---|
Annals of Neurology |
1 | 0.03 |
Clinical Infectious Diseases |
1 | 0.05 |
European Urology |
1 | 0.03 |
Gastroenterology |
1 | 0.02 |
Gut |
1 | 0.04 |
Journal of Clinical Oncology |
1 | 0.05 |
Journal of Infectious Diseases |
5 | 0.44 |
Journal of the National Cancer Institute |
1 | 0.02 |
Nature |
2 | 0.03 |
Nature Communications |
15 | 0.73 |
Nature Medicine |
4 | 0.21 |
Pediatrics |
1 | 0.09 |
Proceedings of the National Academy of Sciences of the United States of America |
1 | 0.13 |
Science |
1 | 0.14 |
Science Advances |
2 | 0.38 |
The Journal of Allergy and Clinical Immunology |
2 | 0.08 |
The New England Journal of Medicine |
2 | 0.19 |
![Creative Commons License](https://i.creativecommons.org/l/by-nc-sa/4.0/80x15.png)
Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.